Sponsor pipeline

Xadcera Biopharmaceutical (Suzhou) Co., Ltd. clinical trial pipeline

Get alerts when Xadcera Biopharmaceutical (Suzhou) Co., Ltd.'s trials change

2 active trials 1 recruiting 5 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-08-29
Primary completion pushed: 2026-08-13 → 2027-01-31
Enrollment closed, study ongoing
Completion pushed: 2027-02-13 → 2027-05-31
NCT06475937 A Study of DM001 in Patients With Advanced Solid Tumors · Phase 1

Active trials by phase

Phase 1
1
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06751329 A Study of DM002 in Patients With Advanced Solid Tumors Ovarian Neoplasms Recruiting 2026-08-07
Phase 1
NCT06475937 A Study of DM001 in Patients With Advanced Solid Tumors Breast Neoplasms Active, Not Recruiting 2026-08-28

Disease areas by active trials

Breast Cancer (1) · Colorectal Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Ovarian Cancer (1) · Pancreatic Cancer (1)

Get alerts when Xadcera Biopharmaceutical (Suzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free